We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.24B
AUM Growth
-$83.1M
Cap. Flow
-$36.7M
Cap. Flow %
-2.97%
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 94.02%
2 Industrials 4.68%
3 Financials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
51
DELISTED
Tourmaline Bio
TRML
$10.4M 0.85%
+71,100
New +$10.9M
ABBV icon
52
AbbVie
ABBV
$465B
$10M 0.81%
89,000
-2,500
-3% -$282K
LH icon
53
Labcorp
LH
$25.2B
$9.57M 0.77%
40,405
-51,332
-56% -$11.7M
MDT icon
54
Medtronic
MDT
$112B
$9.57M 0.77%
77,101
+24,600
+47% +$3.09M
COO icon
55
Cooper Companies
COO
$14.2B
$9.54M 0.77%
96,320
-42,480
-31% -$4.16M
PODD icon
56
Insulet
PODD
$11.8B
$9.54M 0.77%
34,754
-12,600
-27% -$3.43M
EPIX
57
DELISTED
ESSA Pharma
EPIX
$9.48M 0.77%
331,963
-40,000
-11% -$1.16M
NVCR icon
58
NovoCure
NVCR
$1.77B
$9.27M 0.75%
+41,800
New +$8.13M
GH icon
59
Guardant Health
GH
$19.1B
$8.96M 0.73%
72,186
+800
+1% +$108K
CTLT
60
DELISTED
CATALENT, INC.
CTLT
$8.89M 0.72%
82,250
+4,000
+5% +$429K
LLY icon
61
Eli Lilly
LLY
$1.08T
$8.5M 0.69%
37,015
-9,700
-21% -$1.95M
CRL icon
62
Charles River Laboratories
CRL
$11.3B
$8.43M 0.68%
+22,800
New +$7.61M
TDOC icon
63
Teladoc Health
TDOC
$1.66B
$8.42M 0.68%
50,638
-74,075
-59% -$12M
BMY icon
64
Bristol-Myers Squibb
BMY
$129B
$8.39M 0.68%
125,574
HARP
65
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$8.05M 0.65%
58,076
-5,029
-8% -$959K
QTRX icon
66
Quanterix
QTRX
$159M
$7.87M 0.64%
134,186
-109,503
-45% -$6.36M
MOH icon
67
Molina Healthcare
MOH
$10.4B
$7.77M 0.63%
30,697
-7,200
-19% -$1.81M
EXEL icon
68
Exelixis
EXEL
$13.9B
$7.62M 0.62%
418,370
-71,688
-15% -$1.67M
PFE icon
69
Pfizer
PFE
$143B
$7.57M 0.61%
193,400
+106,000
+121% +$4.12M
VOR icon
70
Vor Biopharma
VOR
$1.06B
$7.56M 0.61%
20,266
-6,497
-24% -$3.21M
TMCI icon
71
Treace Medical Concepts
TMCI
$262M
$7.53M 0.61%
+240,765
New +$7.66M
EXAS
72
DELISTED
Exact Sciences
EXAS
$7.27M 0.59%
58,500
+3,500
+6% +$418K
XRAY icon
73
Dentsply Sirona
XRAY
$2.84B
$6.83M 0.55%
+108,000
New +$7.11M
BIIB icon
74
Biogen
BIIB
$30.9B
$6.73M 0.54%
19,432
+6,950
+56% +$2.11M
STAA icon
75
STAAR Surgical
STAA
$1.19B
$6.56M 0.53%
+43,000
New +$5.66M

Similar funds

Sectoral Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Sectoral Asset Management held 139 positions worth $1.24B, down 6.3% from $1.32B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Sectoral Asset Management's Q2 2021 filing shows 26 new, 28 increased, 58 reduced and 12 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M. The largest sale was PPD, Inc. Common Stock, an estimated $32.3M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.

  • Sectoral Asset Management's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 271,206 shares worth $24.3M.
  • Sectoral Asset Management added most to Insmed in Q2 2021, an estimated $16.1M increase.
  • Sectoral Asset Management's biggest Q2 2021 reduction was Atea Pharmaceuticals, cutting an estimated $24M.
  • Sectoral Asset Management fully exited PPD, Inc. Common Stock in Q2 2021, selling an estimated $32.3M.
  • Sectoral Asset Management's ten largest holdings make up 21% of its $1.24B portfolio in Q2 2021.
  • Sectoral Asset Management opened 26 new positions and closed 12 in Q2 2021.
  • Sectoral Asset Management's portfolio value fell 6.3% quarter-over-quarter to $1.24B.

Based on Sectoral Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.